返回 Agenda
S3-2 - What’s new in ICH guidelines? (2)
Session Chair(s)
Myounghee Kim
Senior Director
IQVIA, Korea, Republic of
Nayoung Lee
Vice president, Enterprise Leadership
PAREXEL, Korea, Republic of
Speaker(s)
Nan Wang
GSK, China
Head of Scientific and Medical Writing, Asia Development
Young Su Noh, MPHARM
Hanmi Pharmaceuticals , Korea, Republic of